前列腺癌
化学
雄激素受体
雄激素
抗雄激素
结构-活动关系
雄激素受体拮抗剂
受体
内科学
内分泌学
药理学
癌症
激素
生物化学
体外
医学
作者
Michael E. Jung,Samedy Ouk,Dongwon Yoo,Charles L. Sawyers,Charlie Chen,Chris Tran,John Wongvipat
摘要
A structure-activity relationship study was carried out on a series of thiohydantoins and their analogues 14 which led to the discovery of 92 (MDV3100) as the clinical candidate for the treatment of hormone refractory prostate cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI